Vanguard Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $104M | Buy |
15,470,365
+275,802
| +2% | +$2.08M | ﹤0.01% | 1859 |
|
|
2025
Q3 | $132M | Sell |
15,194,563
-238,649
| -2% | -$1.86M | ﹤0.01% | 1735 |
|
|
2025
Q2 | $97.2M | Sell |
15,433,212
-241,166
| -2% | -$1.6M | ﹤0.01% | 1841 |
|
|
2025
Q1 | $100M | Sell |
15,674,378
-51,872
| -0.3% | -$429K | ﹤0.01% | 1791 |
|
|
2024
Q4 | $126M | Buy |
15,726,250
+296,181
| +2% | +$2.86M | ﹤0.01% | 1763 |
|
|
2024
Q3 | $195M | Buy |
15,430,069
+1,354,696
| +10% | +$17.5M | ﹤0.01% | 1556 |
|
|
2024
Q2 | $178M | Buy |
14,075,373
+582,099
| +4% | +$5.86M | ﹤0.01% | 1551 |
|
|
2024
Q1 | $64.5M | Sell |
13,493,274
-1,066,787
| -7% | -$4.95M | ﹤0.01% | 2062 |
|
|
2023
Q4 | $69.9M | Buy |
14,560,061
+3,008,585
| +26% | +$18.4M | ﹤0.01% | 2040 |
|
|
2023
Q3 | $83.6M | Buy |
11,551,476
+978,873
| +9% | +$7.82M | ﹤0.01% | 1900 |
|
|
2023
Q2 | $78.6M | Buy |
10,572,603
+378,645
| +4% | +$2.98M | ﹤0.01% | 1984 |
|
|
2023
Q1 | $70.6M | Buy |
10,193,958
+1,349,305
| +15% | +$12.4M | ﹤0.01% | 2010 |
|
|
2022
Q4 | $90.9M | Buy |
8,844,653
+1,348,729
| +18% | +$23.8M | ﹤0.01% | 1852 |
|
|
2022
Q3 | $136M | Buy |
7,495,924
+144,999
| +2% | +$6.28M | ﹤0.01% | 1613 |
|
|
2022
Q2 | $378M | Buy |
7,350,925
+383,982
| +6% | +$19.9M | 0.01% | 1026 |
|
|
2022
Q1 | $513M | Buy |
6,966,943
+69,936
| +1% | +$6.24M | 0.01% | 942 |
|
|
2021
Q4 | $987M | Buy |
6,897,007
+100,009
| +1% | +$17.2M | 0.02% | 663 |
|
|
2021
Q3 | $1.41B | Buy |
6,796,998
+126,338
| +2% | +$27.8M | 0.04% | 522 |
|
|
2021
Q2 | $1.42B | Buy |
6,670,660
+777,356
| +13% | +$142M | 0.04% | 527 |
|
|
2021
Q1 | $1.07B | Buy |
5,893,304
+294,544
| +5% | +$58.7M | 0.03% | 601 |
|
|
2020
Q4 | $624M | Buy |
5,598,760
+167,200
| +3% | +$17.8M | 0.02% | 772 |
|
|
2020
Q3 | $589M | Buy |
5,431,560
+793,923
| +17% | +$96.7M | 0.02% | 705 |
|
|
2020
Q2 | $387M | Buy |
4,637,637
+2,579,671
| +125% | +$98.7M | 0.01% | 883 |
|
|
2020
Q1 | $27.9M | Buy |
2,057,966
+576,107
| +39% | +$4.87M | ﹤0.01% | 2137 |
|
|
2019
Q4 | $5.9M | Sell |
1,481,859
-64,975
| -4% | -$282K | ﹤0.01% | 3117 |
|
|
2019
Q3 | $7.76M | Buy |
1,546,834
+146,168
| +10% | +$800K | ﹤0.01% | 2950 |
|
|
2019
Q2 | $8.21M | Buy |
1,400,666
+90,603
| +7% | +$713K | ﹤0.01% | 2972 |
|
|
2019
Q1 | $14.4M | Buy |
1,310,063
+251,623
| +24% | +$7.94M | ﹤0.01% | 2652 |
|
|
2018
Q4 | $39M | Sell |
1,058,440
-58,133
| -5% | -$2.25M | ﹤0.01% | 2148 |
|
|
2018
Q3 | $42M | Buy |
1,116,573
+64,582
| +6% | +$1.82M | ﹤0.01% | 2232 |
|
|
2018
Q2 | $28.2M | Buy |
1,051,991
+248,412
| +31% | +$8.4M | ﹤0.01% | 2412 |
|
|
2018
Q1 | $33.8M | Buy |
803,579
+84,236
| +12% | +$3.38M | ﹤0.01% | 2271 |
|
|
2017
Q4 | $17.8M | Buy |
719,343
+77,857
| +12% | +$1.9M | ﹤0.01% | 2532 |
|
|
2017
Q3 | $14.6M | Sell |
641,486
-228,319
| -26% | -$5.11M | ﹤0.01% | 2636 |
|
|
2017
Q2 | $20M | Sell |
869,805
-214,261
| -20% | -$4.2M | ﹤0.01% | 2458 |
|
|
2017
Q1 | $27.8M | Buy |
1,084,066
+46,929
| +5% | +$1.29M | ﹤0.01% | 2296 |
|
|
2016
Q4 | $26.1M | Buy |
1,037,137
+26,346
| +3% | +$768K | ﹤0.01% | 2300 |
|
|
2016
Q3 | $42M | Buy |
1,010,791
+14,040
| +1% | +$1.81M | ﹤0.01% | 2009 |
|
|
2016
Q2 | $145M | Buy |
996,751
+69,282
| +7% | +$7.94M | 0.01% | 1249 |
|
|
2016
Q1 | $95.7M | Buy |
927,469
+26,578
| +3% | +$2.85M | 0.01% | 1513 |
|
|
2015
Q4 | $151M | Buy |
900,891
+19,286
| +2% | +$2.97M | 0.01% | 1175 |
|
|
2015
Q3 | $125M | Buy |
881,605
+68,263
| +8% | +$15.3M | 0.01% | 1289 |
|
|
2015
Q2 | $181M | Buy |
813,342
+193,700
| +31% | +$34M | 0.01% | 1115 |
|
|
2015
Q1 | $102M | Buy |
619,642
+251,862
| +68% | +$40.9M | 0.01% | 1481 |
|
|
2014
Q4 | $43.6M | Buy |
367,780
+13,679
| +4% | +$1.43M | ﹤0.01% | 1899 |
|
|
2014
Q3 | $29.5M | Buy |
354,101
+12,532
| +4% | +$1.13M | ﹤0.01% | 2057 |
|
|
2014
Q2 | $31.6M | Buy |
341,569
+44,466
| +15% | +$3.91M | ﹤0.01% | 2055 |
|
|
2014
Q1 | $26.9M | Buy |
297,103
+22,911
| +8% | +$2.56M | ﹤0.01% | 2092 |
|
|
2013
Q4 | $28.1M | Buy |
274,192
+60,126
| +28% | +$4.25M | ﹤0.01% | 2044 |
|
|
2013
Q3 | $13.5M | Buy |
214,066
+30,942
| +17% | +$1.74M | ﹤0.01% | 2257 |
|
|
2013
Q2 | $7.51M | Buy |
+183,124
| New | +$7.93M | ﹤0.01% | 2462 |
|
Other funds holding NVAX
SCM
S
Vanguard Group's NVAX Position: Q4 2025 in Review
Vanguard Group increased its Novavax (NVAX) stake by 1.8% in Q4 2025, buying an estimated $2.08M and bringing the position to 15,470,365 shares worth $104M. The position accounts for ﹤0.01% of the portfolio, ranked #1859.
Vanguard Group first reported a position in NVAX in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.42B in Q2 2021. 234 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.
- Vanguard Group held 15,470,365 shares of Novavax worth $104M as of Q4 2025.
- Vanguard Group bought 275,802 Novavax shares in Q4 2025, an estimated $2.08M.
- Novavax made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1859 holding.
- Vanguard Group first reported a position in Novavax in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Novavax position peaked at $1.42B in Q2 2021.
- 234 funds tracked by Wall St. Rank held Novavax as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.